Publication of Supplementary Prospectus
The following supplementary prospectus has been approved by the UK Listing Authority and is available for viewing:
Supplementary Prospectus for the AstraZeneca PLC U.S.$5,000,000,000 Euro Medium Term Note Programme (the Supplementary Prospectus).
To view the full Supplementary Prospectus, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/0604V_-2008-5-22.pdf
The Supplementary Prospectus and the documents incorporated by reference therein are available to the public for inspection at the following addresses:
Document Viewing Facility
UK Listing Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
AstraZeneca PLC
15 Stanhope Gate
London W1K 1LN
G H R Musker
Company Secretary
22 May 2008